Related Experiment Video
Updated: Feb 3, 2026

Endoscopic Endonasal Trans-sphenoidal Approach: Minimally Invasive Surgery for Pituitary Adenomas
Published on: January 17, 2018
Medical therapy for non-functioning pituitary tumors-a critical approach
Metaxia Tampourlou1, Olga Karapanou2, Dimitra A Vassiliadi2
1Department of Endocrinology, Diabetes and Metabolism, Evangelismos Hospital, Athens, Greece. metytab@yahoo.gr.
Abstract:
Non-functioning pituitary adenomas (NFPAs) are the second most common variant of pituitary tumors. When symptomatic, primary therapy is surgery. Recurrence rates are high. Since many NFPAs express dopamine and somatostatin receptors, medical therapy has been used after surgery in order to prevent recurrence. So far, dopamine agonists have been more widely tested with some promise when introduced immediately after surgery but with less efficacy when introduced later upon tumor regrowth. Currently, the role of medical therapy to prevent tumor regrowth in NFPAs is limited by imprecisions as to final outcome and uncertainties concerning on patient selection, dosing, duration, and side effects.
Insights
Non-functioning pituitary adenomas (NFPAs) are common tumors. Medical therapy after surgery may prevent recurrence, but optimal use requires further research on patient selection, dosing, and side effects.
Area of Science:
- Endocrinology
- Neurosurgery
- Oncology
Background:
- Non-functioning pituitary adenomas (NFPAs) are the second most common pituitary tumors.
- Surgery is the primary treatment for symptomatic NFPAs, but recurrence rates are high.
- NFPAs often express dopamine and somatostatin receptors, suggesting potential for medical therapy.
Purpose of the Study:
- To evaluate the role of medical therapy in preventing NFPA recurrence after surgery.
- To address uncertainties regarding patient selection, dosing, duration, and side effects of medical treatments.
Main Methods:
- Review of existing studies on medical therapy for NFPAs post-surgery.
- Analysis of the efficacy of dopamine agonists initiated immediately after surgery versus later upon tumor regrowth.
Main Results:
- Dopamine agonists show some promise when started immediately post-surgery.
- Efficacy is reduced when dopamine agonists are introduced later upon tumor regrowth.
- Current medical therapy for NFPA recurrence prevention is limited by outcome imprecision and uncertainties.
Conclusions:
- The role of medical therapy in preventing NFPA recurrence is currently limited.
- Further research is needed to optimize patient selection, dosing, duration, and manage side effects.
- Refined medical strategies could improve outcomes for patients with NFPAs.
Related Concept Videos
Hypothalamic-Pituitary Axis
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Hormones of the Pituitary Gland
The most abundantly secreted hormone from the anterior lobe is the growth hormone, which controls overall growth by...
The Pituitary Gland
Critical Region, Critical Values and Significance Level
In hypothesis testing, a sample statistic is converted to a test statistic using z, t, or chi-square distribution. A critical region is an area under the curve in probability distributions demarcated by the critical value. When the test statistic falls in this region, it suggests that the null hypothesis must be rejected. As this region contains all those values of the...
Critical Values

